The cost, which is confidential & was negotiated for all in all , 300 huge number of doses, is slightly lower than the $19.50 a picture the United States agreed to buy a very first shipment of hundred million doses of the identical vaccine, in line with what Reuters reported in November.
The EU file dated Nov. 18 was circulated internally after the EU announced its supply deal with Pfizer and the German partner BioNTech of its on Nov. eleven.
The EU drug regulator is actually anticipated to determine on Monday on approval for the Pfizer vaccine after the shot was authorised in several countries, like Britain as well as the United States.
On Thursday Belgian declare secretary on your budget Eva De Bleeker published on Twitter a dining room table with prices Belgium will spend pharmaceutical companies for the COVID 19 vaccines of theirs. She retracted the post shortly after publishing.
In that dinner table the Pfizer vaccine was indicated as costing Belgium twelve euros ($14.6) per dose, leading many to believe that was the total fee agreed by way of the EU.
Various other vaccines in the table were also shown with prices lower than rates disclosed by EU sources.
“There is , naturally, a total price and a price after delivery,” an EU official involved in talks with vaccine creators told Reuters when made to clarify the difference between the EU and Belgian rates.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality requirements, but pointed to what De Bleeker told the Belgian parliament last week. In this public hearing, De Beeker said Belgium’s budgeted price tags were still partial.
Underneath EU advanced purchase deals for COVID 19 vaccines, the bloc agrees initial payments with business enterprises to secure doses before they’re approved. Following approvals, EU governments can pay the rest to purchase reserved doses.
The EU has not revealed the initial transaction agreed with Pfizer.
Nonetheless, it mentioned in October that it paid about one billion euros in downpayments to AstraZeneca, Sanofi and Johnson and Johnson for the shots of theirs, with an additional 1.45 billion euros budgeted for upfront payments to Pfizer BioNTech, Moderna and Curevac.
It has since agreed source deals with all 6 organizations and is negotiating a seventh agreement with Novavax.